Back to search

2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF

Data up to Jan 2025

Published2003
Citations713
References74

Total Citations Per Year

Abstract

References (74)

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.

1995 • 5,971 citations

Mechanisms of angiogenesis

1997 • 5,696 citations

Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma

1991 • 5,657 citations

Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O 2 -Regulated Prolyl Hydroxylation

2001 • 5,255 citations

Hypoxia — a key regulatory factor in tumour growth

2002 • 4,942 citations

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1992 • 4,631 citations

HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing

2001 • 4,537 citations

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

1996 • 4,143 citations

Activation of Vascular Endothelial Growth Factor Gene Transcription by Hypoxia-Inducible Factor 1

1996 • 3,851 citations

C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation

2001 • 3,215 citations

A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF

2001 • 2,481 citations

Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

1998 • 2,427 citations

Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.

1999 • 2,168 citations

HIF-1: mediator of physiological and pathophysiological responses to hypoxia

2000 • 1,769 citations

Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based Screen

1999 • 1,684 citations

HIF-1alpha is required for solid tumor formation and embryonic vascularization

1998 • 1,567 citations

The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages

2000 • 1,272 citations

Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension

1996 • 1,195 citations

Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth

1997 • 1,059 citations

Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylation

2001 • 994 citations

Signal transduction to hypoxia-inducible factor 1

2002 • 843 citations

Clinical Application of Antiangiogenic Therapy: Microvessel Density, What It Does and Doesn't Tell Us

2002 • 794 citations

Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.

2000 • 784 citations

The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth

1994 • 743 citations

Regulation and Destabilization of HIF-1α by ARD1-Mediated Acetylation

2002 • 693 citations

Paclitaxel-resistant Human Ovarian Cancer Cells Have Mutant β-Tubulins That Exhibit Impaired Paclitaxel-driven Polymerization

1997 • 668 citations

The microtubule-affecting drug paclitaxel has antiangiogenic activity.

1996 • 643 citations

Hsp90 Regulates a von Hippel Lindau-independent Hypoxia-inducible Factor-1α-degradative Pathway

2002 • 633 citations

Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature.

1997 • 627 citations

Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer.

2000 • 609 citations

Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer.

2001 • 597 citations

Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis

2001 • 586 citations

Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin.

1994 • 584 citations

Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol.

1997 • 525 citations

Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival

2001 • 467 citations

Mammalian Oxygen Sensing, Signalling and Gene Regulation

2000 • 453 citations

Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo.

1994 • 433 citations

2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site.

1994 • 400 citations

Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.

2002 • 376 citations

Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer

2002 • 343 citations

The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors.

2001 • 333 citations

Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL

2002 • 330 citations

Oxygen sensors and angiogenesis

2002 • 323 citations

Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy.

2001 • 309 citations

Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells.

2002 • 296 citations

Angiogenesis-dependent diseases

2001 • 294 citations

Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients.

2002 • 289 citations

Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability.

2001 • 289 citations

2‐Methoxyestradiol, a Promising Anticancer Agent

2003 • 257 citations

2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate.

2000 • 235 citations

Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines.

2000 • 224 citations

In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug

1999 • 215 citations

2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta.

2002 • 201 citations

Synthesis, Antitubulin and Antimitotic Activity, and Cytotoxicity of Analogs of 2-Methoxyestradiol, an Endogenous Mammalian Metabolite of Estradiol That Inhibits Tubulin Polymerization by Binding to the Colchicine Binding Site

1995 • 185 citations

Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models.

2002 • 179 citations

Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but does not promote tumor growth

2003 • 161 citations

2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells

2002 • 121 citations

Hypoxia: the tumor's gateway to progression along the angiogenic pathway

2001 • 120 citations

SOD1 Down-Regulates NF-κB and c-Myc Expression in Mice after Transient Focal Cerebral Ischemia

2001 • 114 citations

Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cells

2001 • 113 citations

2-Methoxyestradiol Arrests Cells in Mitosis without Depolymerizing Tubulin

1996 • 110 citations

The mammalian metabolite, 2-methoxyestradiol, affects p53 levels and apoptosis induction in transformed cells but not in normal cells

1997 • 100 citations

Synthesis of Analogs of 2-Methoxyestradiol with Enhanced Inhibitory Effects on Tubulin Polymerization and Cancer Cell Growth

1997 • 91 citations

Hypoxia: the tumor's gateway to progression along the angiogenic pathway

2001 • 90 citations

2-Methoxyestradiol Does Not Inhibit Superoxide Dismutase

2001 • 70 citations

Rescue of hypoxia-inducible factor-1alpha-deficient tumor growth by wild-type cells is independent of vascular endothelial growth factor.

2002 • 56 citations

Antiangiogenic and antitumor activity of IDN 5390, a new taxane derivative.

2002 • 55 citations

2-Methoxyestradiol blocks estrogen-induced rat pituitary tumor growth and tumor angiogenesis: possible role of vascular endothelial growth factor.

2000 • 53 citations

Inhibition of Tumor Necrosis Factor α-Stimulated Aromatase Activity by Microtubule-Stabilizing Agents, Paclitaxel and 2-Methoxyestradiol

1999 • 49 citations

Natural Estrogens Induce Modulation of Microtubules in Chinese Hamster V79 Cells in Culture

1996 • 39 citations

Resolution of Subcellular Detail in Thick Tissue Sections: Immunohistochemical Preparation and Fluorescence Confocal Microscopy

2002 • 36 citations

Chapter 11 Resolution of Subcellular Detail in Thick Tissue Sections: Immunohistochemical Preparation and Fluorescence Confocal Microscopy

1993 • 24 citations

Another star on drugs

2000 • 6 citations

SNARE hypothesis 2000

2000 • 5 citations

Cited By (0)

Loading...
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating… (2003) – Cancer Cell | Metascience Observatory Explorer